Erratum to “Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings” [Eur J Cancer 136 (September 2020) 159−168] (European Journal of Cancer (2020) 136 (159–168), (S0959804920303300), (10.1016/j.ejca.2020.06.003))

  1. Castañón, E.
  2. Sanchez-Arraez, A.
  3. Alvarez-Manceñido, F.
  4. Jimenez-Fonseca, P.
  5. Carmona-Bayonas, A.
Aldizkaria:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Argitalpen urtea: 2021

Alea: 142

Orrialdeak: 152-153

Mota: Hutsen zuzenketa

DOI: 10.1016/J.EJCA.2020.10.003 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus